Amgen Inc. buy phonebroker
Start price
29.04.21
/
40%
€196.62
Target price
29.04.22
€217.00
Performance (%)
-3.11%
End price
23.08.21
€190.50
Summary
This prediction ended on 23.08.21 with a price of €190.50. With a performance of -3.11%, the BUY prediction by phonebroker finished with a loss. A total of €2.95 was paid as dividends for this prediction. phonebroker has 40% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Amgen Inc. | 2.483% | 2.483% | 46.010% | 54.129% |
| iShares Core DAX® | -1,59 % | 5,03 % | 6,33 % | 64,06 % |
| iShares Nasdaq 100 | -4,15 % | -0,13 % | 25,73 % | 86,92 % |
| iShares Nikkei 225® | -6,30 % | 0,53 % | 41,38 % | 77,87 % |
| iShares S&P 500 | -3,23 % | 0,47 % | 20,45 % | 68,19 % |
Comments by phonebroker for this prediction
In the thread Amgen Inc. diskutieren
Buy Amgen Inc.
Kursziel gesetzt auf 217,0